Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Sandoz Inc. Recalls Several Lots of Lorazepam Tablets
Sandoz Inc. is recalling several lots of Lorazepam Tablets, USP, 0.5 mg, 1 mg, and 2 mg because the lots did not pass the manufacturer's routine tests for quality and expiration dating. Lorazepam is used in the treatment of anxiety. Lorazepam is also sold under the brand name Ativan. No other lots, strengths, or brands of lorazepam were involved in this recall. To view the FDA notice about this recall and a complete list of recalled lot numbers, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm239148.htm
Learn More

Paddock Laboratories, Inc. Recalls Several Lots of Lorazepam Oral Concentrate, 2 mg/mL
Paddock Laboratories, Inc. has recalled several lots of the liquid Lorazepam Oral Concentrate, 2 mg/ml. The following lot numbers have been recalled because these lots did not pass the manufacturer's routine tests for impurities and by-products from chemical breakdown over time: 2010302121, 2010392922, 2010514031, 2011084759, 2011145313, 2011235889. Lorazepam is used in the treatment of anxiety and seizures. Lorazepam is also sold under the brand name Ativan. No other lots, strengths, or brands of Lorazepam were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm303528.htm
Learn More

Date Published Title Drug Source
2011-01-10 Sandoz Inc. Recalls Several Lots of Lorazepam Tablets Lorazepam FDA
2012-05-15 Paddock Laboratories, Inc. Recalls Several Lots of Lorazepam Oral Concentrate, 2 mg/mL Lorazepam FDA
2012-05-01 Actavis Totowa LLC Recalls Select Lots of Losartan Potassium Tablets, 50 mg Losartan FDA
2008-08-08 Combination use can lead to rare condition of muscle damage Lovastatin FDA
2008-09-03 Statins plus fibrates increase risk of muscle problems Lovastatin MediGuard CRT
2008-11-10 Cholesterol-lowering Medications May Increase Risk of Confusion After Surgery Lovastatin MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Lovastatin MediGuard CRT
2012-02-28 FDA Revises Dose Limitations for Lovastatin (Mevacor) and Lovastatin/Niacin (Advicor) Lovastatin FDA
2008-08-08 Combination use can lead to rare condition of muscle damage Lovastatin and Niacin FDA
2008-09-03 Statins plus fibrates increase risk of muscle problems Lovastatin and Niacin MediGuard CRT
2008-11-10 Cholesterol-lowering Medications May Increase Risk of Confusion After Surgery Lovastatin and Niacin MediGuard CRT
2010-07-23 FDA Publishes Question and Answers about Approval of Generic Version of Lovenox (Enoxaparin Sodium Injection) Lovenox FDA
2012-02-17 Healthcare Professionals Advised That a Single Batch Of Clexane Syringe Needle Caps May Be Difficult To Remove Lovenox MHRA
2012-04-01 Sandoz Inc Recalls Select Lots of Enoxaparin Sodium Injection, 100 mg/mL and 30 mg/mL Lovenox FDA
2008-06-17 New Boxed Warning on Older Class of Antipsychotic Drugs Loxapine FDA
2008-08-04 Generic Manufacturer Recalls Several Drug Products Loxapine Manufacturer
2009-06-08 Antipsychotics Linked With Sudden Cardiac Death Loxapine MediGuard CRT
2012-07-19 Watson Laboratories Recalls Several Lots of Loxapine Capsules Loxapine FDA
2010-05-03 FDA Announces Ongoing Safety Review of Gonadotropin-Releasing Hormone (GnRH) Agonists Lupron FDA
2010-10-21 New Safety Warnings Added to Gonadotropin-Releasing Hormone (GnRH) Agonists Lupron FDA
Back to Consumer Med Safety